Lund Hemodynamic Lab
1 – 10 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Whole genome sequencing in early onset advanced heart failure
- Contribution to journal › Article
-
Mark
Localization, Proteolytic Processing, and Binding Partners of Versican Isoforms in Vascular Lesions of Pulmonary Arterial Hypertension
(2025) In The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 73(3-4). p.129-145
- Contribution to journal › Article
-
Mark
Can Plasma ADAMTS13 Differentiate Patients With Pulmonary Arterial Hypertension From Other Forms of Pulmonary Hypertension and Dyspnea Control Patients
- Contribution to journal › Article
-
Mark
Metabolite Profiles of Heart Failure, Central Hemodynamic Derangement, and Response to Heart Transplantation
- Contribution to journal › Article
-
Mark
Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension
- Contribution to journal › Article
-
Mark
Increased contractility affects left ventricular kinetic energy in pulmonary hypertension
- Contribution to journal › Article
- 2024
-
Mark
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
- Contribution to journal › Article
-
Mark
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
- Contribution to journal › Article
-
Mark
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
- Contribution to journal › Scientific review
-
Mark
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension : A systematic review and meta-analysis
- Contribution to journal › Scientific review
